Recombinant Human EGF Market

Human EGF is a 6-kDa protein with 53 amino acid residues and three intramolecular disulfide bonds. EGF binds to the epidermal growth factor receptor. Initially, human EGF was known as urogastrone. Recombinant Human EGF Market studies the Recombinant Human EGF (Epidermal Growth Factor) obtained by recombinant protein. Recombinant Human EGF Market contains market size and forecasts of Recombinant Human EGF in Global, including the following market information: Global Recombinant Human EGF Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Recombinant Human EGF market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. ?98% SDS-PAGE Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Recombinant Human EGF include FUJIFILM Irvine Scientific, PeproTech, Inc, R&D Systems (Bio-Techne), Miltenyi Biotec, Thermo Fisher Scientific, Abcam PLC, BioLegend Way, STEMCELL Technologies and Eurofins DiscoverX, etc. In 2021, the global top five players have a share approximately % in terms of revenue. We surveyed the Recombinant Human EGF companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Recombinant Human EGF Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Recombinant Human EGF Market Segment Percentages, by Type, 2021 (%) ?98% SDS-PAGE 95%-98% SDS-PAGE <95% SDS-PAGE Global Recombinant Human EGF Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Recombinant Human EGF Market Segment Percentages, by Application, 2021 (%) Scientific Research Medical Drug Others Global Recombinant Human EGF Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Recombinant Human EGF Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Recombinant Human EGF revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Recombinant Human EGF revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: FUJIFILM Irvine Scientific PeproTech, Inc R&D Systems (Bio-Techne) Miltenyi Biotec Thermo Fisher Scientific Abcam PLC BioLegend Way STEMCELL Technologies Eurofins DiscoverX RayBiotech, Inc Prospec-Tany Tonbo Biosciences EnQuire Bio ScienCell Research Laboratories BioVision, Inc Abm Inc Cell Guidance Systems Creative BioMart Sino Biological Cell Sciences Axol Bioscience